Perspectives on the Use of Outpatient Parenteral Antibiotic Therapy for People who Inject Drugs: Results From an Online Survey of Infectious Diseases Clinicians

Daniel A Solomon; Alison M Beieler; Sera Levy; Ellen F Eaton; Monica K Sikka; Alice Thornton; Shireesha Dhanireddy

doi:10.1093/ofid/ofad372

Perspectives on the Use of Outpatient Parenteral Antibiotic Therapy for People who Inject Drugs: Results From an Online Survey of Infectious Diseases Clinicians

Open Forum Infect Dis. 2023 Jul 15;10(7):ofad372. doi: 10.1093/ofid/ofad372. eCollection 2023 Jul.

Authors

Daniel A Solomon¹, Alison M Beieler², Sera Levy³, Ellen F Eaton³, Monica K Sikka⁴, Alice Thornton⁵, Shireesha Dhanireddy⁶

Affiliations

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Harborview Medical Center, Seattle, Washington, USA.
³ University of Alabama, Birmingham, Alabama, USA.
⁴ Oregon Health & Sciences University, Portland, Oregon, USA.
⁵ University of Kentucky, Lexington, Kentucky, USA.
⁶ University of Washington, Seattle, Washington, USA.

Abstract

Injection-related infections require prolonged antibiotic therapy. Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be feasible for people who inject drugs (PWID) in some settings. We report a national survey on practice patterns and attitudes of infectious diseases clinicians in the United States regarding use of OPAT for PWID.

Keywords: OPAT; PWID; substance use disorder.